The FDA has approved revisions to safety labeling for budesonide inhalation powder, efavirenz plus emtricitabine and tenofovir disoproxil fumarate tablets, and tipranavir capsules and oral solution. Medscape Medical News
The association between rhinosinusitis and asthma is supported by strong epidemiological, and pathogenic evidence. Current Opinion in Allergy and Clinical Immunology
Asthma is the leading cause of hospitalization for children younger than 15 years. Asthma action plans are a universally accepted recommendation, but many schoolchildren are without one. Medscape Medical News
The relationship between asthma and chronic rhinosinusitis may be different in Western and non-Western populations, a new study shows. Reuters Health Information